首页 > 市场调查报告书 > 医疗设备

病患监测

市场调查报告书

商品编码

1560807

全球多参数病患监护设备市场 - 2024 - 2031

Global Multiparameter Patient Monitoring Devices Market - 2024 - 2031

出版日期: 2024年09月23日 | 出版商:

DataM Intelligence | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

全球多参数病患监护设备市场在 2023 年达到 111.9 亿美元，预计到 2031 年将达到 233 亿美元，2024-2031 年预测期间复合年增长率为 9.6%。

多参数患者监护设备是必不可少的医疗仪器，使医疗保健专业人员能够同时监测多种生命体征，例如心率、血压、呼吸频率、血氧饱和度和体温。这些设备旨在提供即时资料，这对于做出明智的临床决策、增强患者安全和改善整体护理服务至关重要。

多参数患者监护设备是现代医疗保健中的重要工具，可以连续、即时地追踪生命征象。这些多功能设备在医院和居家护理环境中都是不可或缺的，在改善病患治疗效果方面发挥关键作用。

市场动态：

司机

慢性病发生率上升和技术进步

全球多参数患者监护设备市场的需求是由多种因素所驱动的。主要因素之一是慢性病发病率上升和技术进步。非传染性疾病 (NCD) 发病率的上升已成为紧迫的公共卫生问题，需要有效的监测解决方案来管理这些长期疾病，其中包括心血管疾病、糖尿病、慢性呼吸道疾病和癌症等疾病。

根据世界卫生组织 2023 年 9 月的资料，非传染性疾病 (NCD) 是一个重大的全球健康问题，每年导致约 4,100 万人死亡，占全球死亡人数的 74%。对更好的疾病管理策略的需求不断增长，导致多参数监测设备市场不断增长，这些设备可以同时追踪多个生命体征以提供全面的患者资料。

穿戴式科技、人工智慧和资料分析的进步极大地增强了多参数监视器的功能。无线连接以及与电子健康记录 (EHR) 的无缝整合等功能提高了这些设备的性能和用户体验，从而增加了它们对医疗保健提供者的吸引力。

此外，关键参与者的策略（例如伙伴关係和协作以及创新产品发布）推动了该市场的成长。例如，2023 年 11 月，BioIntelliSense 与加州大学戴维斯分校健康中心合作，为接受骨髓移植和血液学/肿瘤学服务的患者推出了一项新的院内监测计画。这项创新计画利用 BioIntelliSense 经 FDA 批准的 BioButton 穿戴式设备，以及演算法资料分析和临床智慧系统，来监测生命体征趋势的细微变化并检测潜在的患者病情恶化。

此外，2023 年 5 月，Vivalink 宣布了其多参数可穿戴心电图贴片的最新版本，具有连续 14 天的直播功能。这款创新贴片透过单一应用程式实现长时间监测，彻底改变了远端心电图监测，显着减轻了临床医生和患者的负担。

限制

严格的监管框架、设备成本高、资料安全和隐私问题以及缺乏适当报销等因素预计将阻碍市场发展。

细分市场分析

全球多参数患者监护设备市场根据设备类型、严重程度、年龄层、目标区域以及最终用户和地区进行细分。

便携式|紧凑型设备细分市场约占全球多参数患者监护设备市场份额的 68.2%

预计便携式/紧凑型设备领域将在预测期内占据最大的市场份额。便携式多参数患者监护设备旨在测量和显示多种生命体征，包括心率、血压、呼吸频率、氧饱和度和温度，所有这些都采用紧凑的移动设计。便携式监视器提供了增强的灵活性和移动性，使医疗保健提供者能够在医院、门诊诊所和家庭护理环境等不同环境中监测患者。

便携式多参数监视器专为用户友好性而设计，使医疗保健专业人员能够在医院病房或各种医疗保健环境中轻鬆移动它们。其轻巧紧凑的设计提高了患者的舒适度和移动性，方便了护理服务，而无需将患者限制在医院病床上。远距医疗服务的成长显着增加了对便携式监测设备的需求。这些设备可以轻鬆地将患者资料远距离发送给医疗保健提供者，从而实现持续监控并支援虚拟咨询。这种整合提高了患者的参与度并实现了健康状况的主动管理。

此外，该行业的主要参与者推出了创新平台和便携式设备的关键发展，推动了该市场的成长。例如，2024 年 1 月，Blue Spark Technologies, Inc. 推出了 VitalTraq，这是一个创新的多感测器远端患者监护平台。此创新平台采用最先进的非接触式生命征象测量感测器之一－远端光电体积描记法 (rPPG)。透过 30 至 60 秒的快速自拍扫描，患者、临床医生和研究人员可以获得心率、心率变异性、血压和呼吸频率等生命体征的数位测量结果，所有这些都在一次非接触式体验中完成。

同样，2024 年 1 月，Pylo Health 宣布推出两款先进的病患设备：Pylo 900-LTE 血压监测仪和 Pylo 200-LTE 体重计。这两款设备都经过了临床验证，旨在连接到多个蜂窝网络，确保在美国各地进行可靠的资料传输。 Pylo 900-LTE和200-LTE与Prevounce远端护理管理平台相容，还可透过Pylo云端API与各种独立健康应用和管理系统整合。

市场地理分析

北美约占全球多参数患者监护设备市场份额的43.2%

由于北美人口老化的加剧是推动多参数患者监护设备市场成长的关键因素，预计北美地区将在预测期内占据最大的市场份额。随着越来越多的人步入老年，慢性病的盛行率上升，需要持续监测以有效管理他们的健康状况。

根据人口资料局2024年1月的资料，到2050年，美国将有约8,900万公民年龄在65岁以上。美国心臟协会表示，美国约有 4,000 万 65 岁及以上的人患有心血管疾病。老年人慢性病负担的增加是推动多参数监测设备需求的重要因素。

此外，大量关键参与者的存在、先进的医疗保健基础设施、关键参与者的策略（例如伙伴关係和协作）、技术进步以及产品发布和批准将推动该地区的市场成长。例如，2023 年 10 月，迈瑞与 Edwards Lifesciences 的合作达到了一个重要里程碑，Edwards Lifesciences 是结构性心臟病和重症监护监测医疗解决方案的顶级创新者。这一里程碑使迈瑞的 BeneVision N 系列成为北美市场上第一个与 Edwards FloTrac 感测器整合用于血流动力学监测的患者监测系统。

此外，2023 年 6 月，皇家飞利浦宣布获得 FDA 批准，可以在飞利浦的 IntelliVue MX750 和 MX850 患者监视器中启用 SedLine 脑功能监测、区域血氧测定 (O3) 和 CO2 测量。这项进展标誌着两家公司之间持续合作的最新阶段，旨在使临床医生能够在不需要额外监测设备的情况下做出快速、明智的决策。整合这些先进的监测功能将使医疗保健提供者能够使用单一监测器评估脑血饱和度、麻醉镇静和呼吸性能，从而提高患者护理的效率和成本效益。

Multiparameter patient monitoring devices are essential medical instruments that enable healthcare professionals to monitor multiple vital signs simultaneously, such as heart rate, blood pressure, respiratory rate, oxygen saturation, and temperature. These devices are designed to provide real-time data, which is crucial for making informed clinical decisions, enhancing patient safety, and improving overall care delivery.

Multiparameter patient monitoring devices are essential tools in modern healthcare that enable continuous, real-time tracking of vital signs. These versatile devices are indispensable in both hospital and home care settings, playing a critical role in improving patient outcomes.

Market Dynamics: Drivers

Rising incidence of chronic diseases and technological advancements

The demand for the global multiparameter patient monitoring devices market is driven by multiple factors. One of the primary factors is the rising incidence of chronic diseases and technological advancements. The rising incidence of noncommunicable diseases (NCDs) has become a pressing public health concern, necessitating effective monitoring solutions for managing these long-term illnesses, which include conditions such as cardiovascular diseases, diabetes, chronic respiratory diseases, and cancers.

As per WHO data in September 2023, noncommunicable diseases (NCDs) pose a major global health issue, responsible for around 41 million deaths annually, which accounts for 74% of all fatalities worldwide. This increasing demand for better disease management strategies has led to a growing market for multiparameter monitoring devices, which can track multiple vital signs simultaneously to provide comprehensive patient data.

Advancements in wearable technology, artificial intelligence, and data analytics have greatly enhanced the functionality of multiparameter monitors. Features like wireless connectivity and seamless integration with electronic health records (EHRs) improve the performance and user experience of these devices, increasing their attractiveness to healthcare providers.

Moreover, key player's strategies such as partnerships & collaborations, and innovative product launches drive this market growth. For instance, in November 2023, BioIntelliSense, partnered with UC Davis Health in California to launch a new in-hospital monitoring initiative for patients undergoing Bone Marrow Transplant and Hematology/Oncology services. This innovative program utilizes BioIntelliSense's FDA-cleared BioButton wearable devices, along with algorithmic data analytics and a clinical intelligence system, to monitor subtle changes in vital sign trends and detect potential patient deterioration.

Also, in May 2023, Vivalink announced the latest iteration of its multi-parameter wearable ECG patch, featuring continuous 14-day live streaming capabilities. This innovative patch revolutionizes remote ECG monitoring by enabling extended-duration monitoring with a single application, significantly reducing the burden on both clinicians and patients.

Restraints

Factors such as the stringent regulatory framework, high cost of devices, data security and privacy concerns, and lack of proper reimbursement are expected to hamper the market.

Market Segment Analysis

The global multiparameter patient monitoring devices market is segmented based on device type, acuity level, age group, target area, and end-user and region.

The portable|compact devices segment accounted for approximately 68.2% of the global multiparameter patient monitoring devices market share

The portable/compact devices segment is expected to hold the largest market share over the forecast period. Portable multiparameter patient monitoring devices are engineered to measure and display several vital signs, including heart rate, blood pressure, respiratory rate, oxygen saturation, and temperature, all within a compact and mobile design. Portable monitors offer enhanced flexibility and mobility, allowing healthcare providers to monitor patients across diverse settings such as hospitals, outpatient clinics, and home care environments.

Portable multiparameter monitors are built for user-friendliness, enabling healthcare professionals to move them effortlessly within hospital wards or across various healthcare settings. Their lightweight and compact design improves patient comfort and mobility, facilitating care delivery without requiring patients to remain confined to a hospital bed. The growth of telehealth services has significantly increased the demand for portable monitoring devices. These devices can effortlessly send patient data to healthcare providers from a distance, allowing for ongoing monitoring and supporting virtual consultations. This integration boosts patient engagement and enables proactive management of health conditions.

Moreover, key players in the industry introducing innovative platforms and key developments in portable devices driving this market growth. For instance, in January 2024, Blue Spark Technologies, Inc., is launching VitalTraq, An innovative multi-sensor remote patient monitoring platform. This innovative platform features one of the most advanced contactless vital sign measurement sensors available, Remote Photoplethysmography (rPPG). With a quick 30 to 60-second selfie scan, patients, clinicians, and researchers can obtain digital measurements of vital signs such as heart rate, heart rate variability, blood pressure, and respiratory rate, all in a single contactless experience.

Similarly, in January 2024, Pylo Health announced the launch of two advanced patient devices the Pylo 900-LTE blood pressure monitor and the Pylo 200-LTE weight scale. Both devices have undergone clinical validation and are designed to connect to multiple cellular networks, ensuring reliable data transmission across the United States. The Pylo 900-LTE and 200-LTE are compatible with the Prevounce remote care management platform and can also integrate with various independent health applications and management systems through the Pylo cloud API.

Market Geographical Analysis

North America accounted for approximately 43.2% of the global multiparameter patient monitoring devices market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing aging population in North America is a key factor driving the growth of the multiparameter patient monitoring devices market. As more individuals reach older age, the prevalence of chronic diseases rises, creating a need for ongoing monitoring to effectively manage their health conditions.

According to Population Reference Bureau data in January 2024, by 2050, approximately 89 million citizens in the United States will be over the age of 65. Conditions such as cardiovascular diseases, diabetes, and respiratory disorders are increasingly prevalent among the elderly population. The American Heart Association has indicated that approximately 40 million individuals aged 65 and older in the U.S. are affected by cardiovascular diseases. This rising burden of chronic illnesses in older adults is a significant factor driving the demand for multiparameter monitoring devices.

Moreover, a major number of key players' presence, well-advanced healthcare infrastructure, key players' strategies such as partnerships & collaborations, technological advancements, and product launches & approvals would propel this market growth in this region. For instance, in October 2023, Mindray reached a significant milestone in its partnership with Edwards Lifesciences, a top innovator in medical solutions for structural heart disease and critical care monitoring. This milestone establishes Mindray's BeneVision N-Series as the first patient monitoring system in the North American market to integrate with Edwards' FloTrac sensor for hemodynamic monitoring.

Also, in June 2023, Royal Philips announced that they received FDA clearance to enable SedLine Brain Function Monitoring, Regional Oximetry (O3), and CO2 measurements in Philips' IntelliVue MX750 and MX850 patient monitors. This development marks the latest phase in the ongoing collaboration between the two companies, aimed at empowering clinicians to make swift and informed decisions without requiring additional monitoring devices. Integrating these advanced monitoring capabilities will allow healthcare providers to assess brain blood saturation, anesthetic sedation, and respiratory performance using a single monitor, enhancing the efficiency and cost-effectiveness of patient care.

Market Segmentation

By Device Type

Portable/Compact Devices

Fixed Devices

By Acuity Level

High Acuity Level

Mid Acuity Level

Low Acuity Level

By Age Group

Pediatric

Adult

Geriatric

By Target Area

Cardiology

Neurology

Respiratory

Fetal and Neonatal

Temperature Monitoring

Others

By End-User

Hospitals

Ambulatory Surgical Centers (ASCs)

Homecare Settings

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the multiparameter patient monitoring devices market include Koninklijke Philips N.V., Medtronic, GE HealthCare, Baxter, SternMed GmbH, Dragerwerk AG & Co. KGaA, Masimo, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., ICU Medical, Inc., and Schiller among others.

Key Developments

In June 2024, Prevounce Health, a leading provider of remote care management software, devices, and services, launched its first remote blood glucose monitoring device, the Pylo GL1-LTE. This clinically validated blood glucose meter connects to multiple cellular networks to ensure reliable data transmission throughout the United States. The GL1-LTE is designed for use with the Prevounce remote care management platform and can seamlessly integrate with other health software through the Pylo cloud API. Prevounce's range of Pylo cellular-connected devices also includes blood pressure monitors and weight scales.

In October 2023, Masimo received FDA de novo clearance to incorporate the Oxygen Reserve Index (ORi) calculations into its pulse oximeters, marking a significant advancement in noninvasive patient monitoring. The ORi is designed to provide continuous, real-time insights into a patient's oxygenation status, particularly in the moderate hyperoxic range, which is crucial for patients receiving supplemental oxygen during surgical procedures.

Why Purchase the Report?

To visualize the global multiparameter patient monitoring devices market segmentation based on device type, acuity level, age group, target area, and end-user and region, and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the multiparameter patient monitoring devices market with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global multiparameter patient monitoring devices market report would provide approximately 78 tables, 75 figures, and 184 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Device Type
3.2. Snippet by Acuity Level
3.3. Snippet by Age Group
3.4. Snippet by Target Area
3.5. Snippet by End-User
3.6. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Incidence of Chronic Diseases and Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Stringent Regulatory Framework
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Device Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 6.1.2. Market Attractiveness Index, By Device Type
6.2. Portable/Compact Devices *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Fixed Devices

7. By Acuity Level

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Acuity Level
- 7.1.2. Market Attractiveness Index, By Acuity Level
7.2. High Acuity Level *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Mid Acuity Level
7.4. Low Acuity Level

8. By Age Group

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 8.1.2. Market Attractiveness Index, By Age Group
8.2. Pediatric *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Adult
8.4. Geriatric

9. By Target Area

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Area
- 9.1.2. Market Attractiveness Index, By Target Area
9.2. Cardiology *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Neurology
9.4. Respiratory
9.5. Fetal and Neonatal
9.6. Temperature Monitoring
9.7. Others

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgical Centers (ASCs)
10.4. Homecare Settings
10.5. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Acuity Level
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Area
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.8.1. U.S.
  - 11.2.8.2. Canada
  - 11.2.8.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Acuity Level
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Area
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.8.1. Germany
  - 11.3.8.2. U.K.
  - 11.3.8.3. France
  - 11.3.8.4. Spain
  - 11.3.8.5. Italy
  - 11.3.8.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Acuity Level
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Area
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.8.1. Brazil
  - 11.4.8.2. Argentina
  - 11.4.8.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Acuity Level
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Area
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.8.1. China
  - 11.5.8.2. India
  - 11.5.8.3. Japan
  - 11.5.8.4. South Korea
  - 11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Acuity Level
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Area
- 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Koninklijke Philips N.V.*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Medtronic
13.3. GE HealthCare
13.4. Baxter
13.5. SternMed GmbH
13.6. Dragerwerk AG & Co. KGaA
13.7. Masimo
13.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.9. ICU Medical, Inc.
13.10. Schiller (*LIST NOT EXHAUSTIVE)